Pelvic Inflammatory Disease: Pelvic inflammatory disease (PID) is an acute or chronic inflammation in the pelvic cavity. It is most commonly caused by sexually transmitted diseases, including chlamydia and gonorrhea that have ascended into the uterus, fallopian tubes, or ovaries as a result of intercourse or childbirth, or of surgical procedures, including insertion of IUDs or abortion. PID may be either symptomatic or asymptomatic. It may cause infertility and it may raise the risk of ectopic pregnancy. PID is a disease associated with HIV infection.
Female pelvic inflammatory disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
N14_FEMPELINFINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
143 |
4. Check minimum number of eventsNone |
143 |
5. Include endpointsNone |
143 |
6. Filter based on genotype QC (FinnGen only) |
138 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Female pelvic inflammatory disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of female pelvic organs
- Genitourinary diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1114 | 1114 | - |
| Only index persons | 1099 | 1099 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | - |
| Only index persons | 0.04 | 0.04 | - |
| Median age at first event (years) | |||
| Whole population | - | 23.59 | - |
| Only index persons | - | 23.53 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 138 | 138 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 24.80 | 24.80 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 143
- Matched controls
- 1430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N74.4*A56.1
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
149.4
116
*
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
44.0
28.0
34
10
P01AB01
ATC
metronidazole; oral, rectal
6.2
23.6
104
430
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
44.9
21.6
26
7
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
5.2
20.4
60
174
A56.1
ICD-10 Finland
Chlamydial infection of pelviperitoneum and other genitourinary organs
+∞
20.3
19
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.6
17.2
96
441
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.4
17.2
83
344
N70.0
ICD-10 Finland
Acute salpingitis and oophoritis
178.7
15.8
16
*
N06AB05
ATC
paroxetine; oral
5.6
11.2
23
47
N76.0
ICD-10 Finland
Acute vaginitis
4.2
10.7
33
95
N02AX02
ATC
tramadol; systemic, rectal
3.2
10.6
65
294
N74.4
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
10.5
10
*
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
+∞
10.5
10
*
M77.1
ICD-10 Finland
Lateral epicondylitis
4.8
10.1
25
60
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.4
9.7
45
170
N71.9
ICD-10 Finland
Inflammatory disease of uterus, unspecified
23.6
9.5
13
6
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.0
9.5
90
512
J01AA02
ATC
doxycycline; systemic
4.0
9.3
120
811
M79.6
ICD-10 Finland
Pain in limb
2.9
9.1
79
425
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.6
8.7
33
109
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.2
8.5
42
164
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.2
8.4
25
69
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
3.6
8.3
32
107
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
8.0
41
163
R10.0
ICD-10 Finland
Acute abdomen
10.2
7.5
14
15
D73
ICPC
Gastroenteritis presumed infection
4.4
7.4
20
51
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.9
7.4
45
196
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
+∞
7.3
7
*
N05AH04
ATC
quetiapine; oral
2.8
7.2
47
212
SPAT1240
SPAT
Therapeutic discussion
3.0
7.1
39
160
JAH01
NOMESCO Finland
Laparoscopy
7.8
6.9
15
21
R51.80
ICD-10 Finland
Headache
2.8
6.8
45
204
L29
ICD-10 Finland
Pruritus
23.8
6.8
9
*
Z72.0
ICD-10 Finland
Tobacco use
10.8
6.7
12
12
O60
ICD-10 Finland
Preterm labour and delivery
4.3
6.7
18
46
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
3.1
6.6
32
122
W19
ICD-10 Finland
Unspecified fall
4.4
6.4
17
43
LCH11
NOMESCO Finland
Pharmacologic abortion
3.4
6.3
25
84
N70.9
ICD-10 Finland
Salpingitis and oophoritis, unspecified
+∞
6.3
6
*
TLC02
NOMESCO Finland
Simple extraction of IUD
4.0
6.3
19
53
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.8
6.2
38
165
SPAT1263
SPAT
Sampling
2.4
6.1
75
452
SPAT1283
SPAT
Restricted health certificate
2.4
6.1
58
312
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
256
3.13
9.68
2.1
2.0
47.96
54.93
u/l
1.51
50
240
82
457
2.86
8.72
3.5
2.2
—
—
—
0
0
79
447
2.71
7.93
3.1
4.8
8.09
9.11
umol/l
0.73
71
419
44
188
2.94
7.53
3.0
2.3
2625.34
5481.71
u/l
0.44
17
87
73
410
2.59
7.26
3.3
2.0
—
—
—
0
0
50
237
2.71
6.97
2.0
2.4
7.07
13.11
ng/l
2.16
15
76
53
298
2.24
4.84
3.1
2.6
—
—
—
0
0
54
311
2.18
4.61
2.2
1.7
—
—
—
0
0
132
1098
3.63
4.54
7.8
7.1
3.88
3.87
mmol/l
0.24
125
1049
44
242
2.18
4.16
1.8
1.6
—
—
—
0
0
83
593
1.95
3.72
3.9
2.9
0.00
0.00
estimate
-0.00
20
128
42
237
2.09
3.67
2.5
2.4
0.42
0.32
e6/l
0.15
30
173
82
585
1.94
3.67
5.2
4.0
0.00
0.00
estimate
-0.00
21
124
107
841
2.08
3.57
3.1
2.4
61.83
27.60
u/l
0.89
98
811
32
165
2.21
3.50
1.4
1.5
1.41
1.27
%
0.68
26
148
7
11
6.62
3.22
1.0
1.3
—
—
—
0
0
43
258
1.95
3.13
10.5
6.5
0.96
1.04
inr
2.43
16
95
81
597
1.82
3.08
3.9
3.0
0.00
0.00
estimate
-0.00
22
120
50
320
1.86
2.98
4.1
3.1
0.00
0.00
estimate
-0.00
20
123
120
1013
2.15
2.90
4.4
4.5
14.46
14.17
pmol/l
0.73
113
964
77
566
1.78
2.89
3.1
3.6
6.26
6.06
mmol/l
0.37
66
476
42
264
1.84
2.61
1.7
1.8
—
—
—
0
0
7
16
4.54
2.50
1.9
1.4
—
—
—
0
0
95
761
1.74
2.48
4.9
5.7
70.80
69.99
u/l
0.08
85
717
65
470
1.70
2.48
3.8
2.8
—
—
—
0
0
5
8
6.43
2.39
3.4
1.9
—
—
—
0
0
25
136
2.02
2.36
1.7
1.6
—
—
—
0
0
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
5
9
5.71
2.23
1.0
1.3
—
—
—
0
0
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
9
5.71
2.23
5.0
1.3
100.20
136.00
%
—
5
9
101
836
1.71
2.21
3.4
3.1
7.82
7.88
mm/h
0.03
92
792
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
134
1231
2.41
2.04
7.6
7.1
21.20
22.44
u/l
0.52
127
1196
120
1055
1.85
1.98
7.2
6.8
99.68
98.83
ml/min/173m2
0.19
98
823
61
458
1.58
1.89
1.9
1.5
—
—
—
0
0
14
67
2.21
1.83
2.5
2.5
—
—
—
0
0
129
1171
2.04
1.77
5.1
5.0
1.49
1.65
mu/l
1.13
118
1120
47
342
1.56
1.63
1.3
1.3
0.61
1.21
u/ml
1.00
16
93
49
365
1.52
1.52
2.9
3.0
23.36
25.54
u/l
0.60
44
349
16
89
1.90
1.44
1.6
1.4
—
—
—
0
0
116
1039
1.62
1.43
3.9
2.9
5.44
5.51
mmol/l
0.42
104
980
22
137
1.72
1.39
1.9
1.9
1.22
0.93
e6/l
—
10
78
5
17
3.01
1.37
1.0
1.2
—
—
—
0
0
5
17
3.01
1.37
1.2
1.1
—
—
—
0
0
59
465
1.46
1.36
1.8
1.7
—
—
—
0
0
20
123
1.73
1.32
2.0
2.1
2.26
4.95
e6/l
—
8
63
5
18
2.84
1.29
1.0
1.1
—
—
—
0
0
115
1037
1.56
1.28
2.8
2.6
1.19
1.13
mmol/l
0.35
108
997
120
1094
1.60
1.25
3.2
2.9
4.83
4.74
mmol/l
0.60
112
1056
12
64
1.96
1.22
1.7
1.6
—
—
—
0
0
129
1202
1.75
1.17
11.2
8.4
20.24
16.66
mg/l
0.66
113
889
14
81
1.81
1.13
2.7
3.9
—
—
—
0
0
43
330
1.43
1.12
2.7
4.4
1.24
1.22
mmol/l
1.26
35
312
37
276
1.46
1.11
1.7
1.7
0.38
0.73
mg/l
3.26
29
200
16
100
1.68
1.02
1.1
1.4
—
—
—
0
0
7
35
2.05
1.01
4.9
2.6
—
—
—
0
0
9
49
1.89
1.01
1.2
1.4
—
—
—
0
0
118
1088
1.48
0.99
3.2
2.9
1.49
1.53
mmol/l
0.61
109
1049
39
301
1.41
0.98
1.9
1.8
2.74
2.62
mg/l
0.14
33
268
72
615
1.34
0.96
2.3
2.3
—
—
—
0
0
6
27
2.27
0.94
4.0
1.9
12.83
13.48
%
—
6
27
29
213
1.45
0.94
1.3
1.3
21.16
22.08
nmol/l
0.11
23
194
6
28
2.19
0.92
1.0
1.1
—
—
—
0
0
18
120
1.57
0.90
1.4
1.6
—
—
—
0
0
101
913
1.36
0.89
4.2
3.4
36.91
36.47
mmol/mol
0.21
93
878
118
1098
1.43
0.84
3.4
3.0
2.91
2.84
mmol/l
0.39
109
1057
44
359
1.33
0.77
1.5
1.7
96.42
95.50
pmol/l
0.04
23
208
6
34
1.80
0.77
4.2
2.9
1.37
-0.37
mmol/l
—
6
24
9
54
1.71
0.76
1.1
1.7
—
—
—
0
0
7
40
1.79
0.72
2.1
1.6
101.00
98.72
%
—
7
40
7
40
1.79
0.72
1.3
2.2
—
—
—
0
0
7
41
1.74
0.71
5.9
1.8
0.20
0.25
g/l
—
7
41
7
41
1.74
0.71
1.0
1.5
—
—
—
0
0
75
664
1.27
0.70
3.7
7.2
4.58
3.85
e9/l
1.85
68
586
41
336
1.31
0.70
3.3
3.8
36.75
37.59
g/l
0.45
35
318
5
27
1.88
0.69
1.2
1.1
—
—
—
0
0
13
87
1.54
0.66
1.6
1.6
—
—
—
0
0
31
248
1.32
0.62
1.4
1.3
9.49
32.88
iu/ml
—
8
71
37
304
1.29
0.62
2.2
2.6
2.36
2.34
mmol/l
0.38
30
282
25
196
1.33
0.58
1.2
1.5
—
—
—
0
0
8
124
0.62
0.57
1.6
1.5
—
—
—
0
0
6
37
1.65
0.56
5.8
1.8
116.17
147.51
%
—
6
37
6
38
1.60
0.55
1.2
2.3
—
—
—
0
0
6
40
1.52
0.52
1.7
1.3
—
—
—
0
0
44
378
1.24
0.51
3.3
5.2
1.24
1.22
mmol/l
1.51
36
334
11
76
1.48
0.49
1.2
1.3
3.26
2.91
ug/l
0.16
11
70
11
78
1.44
0.44
1.3
1.3
—
—
—
0
0
11
78
1.44
0.44
1.2
1.3
—
—
—
0
0
11
78
1.44
0.44
4.8
4.0
0.99
1.00
mmol/l
0.06
11
72
5
31
1.63
0.43
1.2
1.4
—
—
—
0
0
8
59
1.38
0.41
1.4
1.6
0.40
0.47
nmol/l
—
8
49
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
22
183
1.24
0.34
1.1
1.4
—
—
—
0
0
22
183
1.24
0.34
1.1
1.4
—
—
—
0
0
22
184
1.23
0.33
1.1
1.4
—
—
—
0
0
22
184
1.23
0.33
1.1
1.4
—
—
—
0
0
12
153
0.76
0.32
1.5
1.6
—
—
—
0
0
29
252
1.19
0.30
1.4
1.3
1.00
8.50
u/ml
—
9
111
52
475
1.15
0.30
2.0
2.2
72.23
72.11
nmol/l
0.01
46
453
7
56
1.26
0.30
1.7
1.5
—
—
—
0
0
121
1173
1.21
0.29
4.7
4.2
—
—
—
0
0
29
253
1.18
0.29
1.5
1.5
1.83
1.34
mmol/l
0.41
24
227
8
63
1.29
0.28
3.0
6.4
106.00
105.90
mmol/l
—
8
63
5
42
1.20
0.21
1.6
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
14.97
—
0
12
6
48
1.26
0.20
1.0
1.0
—
9.93
—
0
9
11
91
1.23
0.18
1.0
1.0
—
—
—
0
0
5
43
1.17
0.10
1.0
2.0
5.96
5.55
kpa
—
5
43
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
16
175
0.90
0.09
1.9
1.4
—
—
—
0
0
5
61
0.81
0.08
1.6
2.4
—
—
—
0
0
9
86
1.05
0.07
2.0
1.7
5.72
2.90
mg/l
—
9
58
18
170
1.07
0.04
4.1
4.3
2.59
12.81
mg/mmol
1.83
11
116
23
223
1.04
0.01
1.4
1.4
—
—
—
0
0
34
333
1.03
0.01
1.4
1.5
—
—
—
0
0
13
134
0.97
0.00
1.9
1.7
—
—
—
0
0
17
168
1.01
0.00
1.2
1.3
334.70
156.64
iu/ml
—
5
72
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
10.25
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
6.12
—
0
5
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
23.27
—
0
7
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
12.14
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
7.54
—
0
7
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_FEMPELINFINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_FEMPELINFINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_FEMPELINFINOTH – Female pelvic inflammatory disorders in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data